Difamilast

Brand names: Adquey · Active ingredient: Difamilast

In short: ADQUEY is indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis.

Forms & strengthsOintment: 1% (10 mg of difamilast per gram) of white to off-white ointment.
LabelAcrotech Biopharma Inc
Label updatedAug 25, 2026

What is Difamilast used for?

ADQUEY is indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis.

Difamilast dosage

ADQUEY is for topical use only and not for ophthalmic, oral, or intravaginal use. Apply a thin layer of ADQUEY twice daily to affected areas and rub in completely. Wash hands after application. Avoid areas of the skin that are infected when applying ADQUEY.

How to take Difamilast — instructions & advice from the label

Advise patients or caregivers to read the FDA-approved patient labeling (Patient Information).

Administration

Advise patients or caregivers that ADQUEY is for topical use only and is not for ophthalmic, oral, or intravaginal use .

Lactation

Advise breastfeeding women not to apply ADQUEY directly to the nipple or areola to minimize potential infant exposure. Instruct patients to avoid inadvertent contact of treated areas with the infant’s skin .

(Made in Canada)

Manufactured for: Acrotech Biopharma Inc East Windsor, NJ 08520 USA

PATIENT INFORMATION

ADQUEYTM (ahd kway)

(difamilast) ointment, for topical use

Important information: ADQUEY is for use on the skin (topical use) only. Do not use ADQUEY near or in your eyes, mouth, or vagina.

What is ADQUEY?

ADQUEY is a prescription medicine used on the skin (topical) to treat adults and children 2 years of age and older with mild to moderate atopic dermatitis. It is not known if ADQUEY is safe and effective in children younger than 2 years of age.

Before using ADQUEY, tell your healthcare provider about all your medical conditions,

including if you:

are pregnant or plan to become pregnant. …

Warnings & precautions

Do not take this medicine if: None.

Difamilast side effects

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

The safety of ADQUEY was assessed in two double-blind, vehicle-controlled clinical trials (Trial 2 and Trial 3) that enrolled 532 adult and pediatric subjects 2 years of age and older in Japan with mild to moderate atopic dermatitis (AD). Subjects applied ADQUEY or vehicle ointment topically twice daily for 4 weeks . Adverse reactions reported by ≥1% of ADQUEY-treated subjects and more frequently than in subjects receiving vehicle are listed in Table 1.

Table 1: Adverse Reactions Occurring in ≥1% of Adult and Pediatric Subjects 2 Years of Age and Older Treated with ADQUEY for Mild to Moderate Atopic Dermatitis (and Greater than Vehicle) through Week 4 in Trials 2 and 3

Adverse Reaction | ADQUEY (N=267) n (%) | Vehicle (N=265)

n (%)

Nasopharyngitis | 16(6) | 10(4)

Less common (<1%) adverse reactions in subjects treated with ADQUEY in Trials 2 and 3 included application site folliculitis, contact dermatitis, application site rash, and molluscum contagiosum.

In Trial 1, a vehicle-controlled dose ranging trial, 43 subjects 10 years of age and older in the United States, Australia, and Poland received ADQUEY topically twice daily for 8 weeks and the safety profile was consistent with Trials 2 and 3. …

About this medicine

ADQUEY (difamilast) ointment contains difamilast as the active ingredient. Difamilast, is a phosphodiesterase-4 (PDE-4) inhibitor. Difamilast is described chemically as N-({2-[4-(Difluoromethoxy)-3-(propan-2-yloxy)phenyl]-1,3-oxazol-4-yl}methyl)-2-ethoxybenzamide. The empirical formula is C23H24F2N2O5 and the molecular weight is 446.44 g/mol. The structural formula is represented below:

Difamilast occurs as white (or practically white) crystals or crystalline powder. It is very soluble in N-methylpyrrolidone, freely soluble in methanol and ethanol (99.5), and practically insoluble in water. It shows crystal polymorphism. Each gram of ADQUEY contains 1% difamilast (w/w) in a wax-based, white to off-white ointment containing the following inactive ingredients: mineral oil, paraffin, propylene carbonate, white petrolatum, and white wax.

How it works: Difamilast is an inhibitor of phosphodiesterase-4 (PDE-4). …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 46c95e41-fa29-4e11-9d94-0fd4f0291c34. Read the full official label on DailyMed.

Related medicines

Doxycycline Adalimumab Ketoconazole Levocetirizine Cyclosporine Tretinoin Brimonidine Dupilumab